Panolog Cream

Hazard statements (CLP)

H317, H334, H350, H360

Code

Statements

H317

May cause an allergic skin reaction

SECTION 2: Hazards identification

Appearance Yellow amber viscous cream Classification of the Substance or Mixture GHS - Classification Respiratory Sensitization: Category 1 Skin Sensitization: Category 1 Reproductive Toxicity: Category 1B Carcinogenicity: Category 1B EU Classification EU Indication of danger Carcinogenic: Category 2 EU Symbol T EU Risk Phrases R45 - May cause cancer.

Signal word

Danger

Hazard statements

H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled H317 - May cause an allergic skin reaction H360 - May damage fertility or the unborn child H350 - May cause cancer

Precautionary statements

P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood P280 - Wear protective gloves/protective clothing/eye protection/face protection P261 - Avoid breathing dust/fume/gas/mist/vapors/spray P285 - In case of inadequate ventilation wear respiratory protection P272 - Contaminated work clothing should not be allowed out of the workplace P308 + P313 - IF exposed or concerned: Get medical attention/advice P304 + P340 - IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing P342 + P311 - If experiencing respiratory symptoms: Call a POISON CENTRE or doctor/physician P302+ P352 - IF ON SKIN: Wash with plenty of soap and water P333 + P313 - If skin irritation or rash occurs: Get medical advice/attention P362 - Take off contaminated clothing and wash before reuse P405 - Store locked up P501 - Dispose of contents/container in accordance with all local and national regulations

Other hazards

Short Term Individuals sensitive to this chemical or other materials in its chemical class may develop allergic reactions. Signs and symptoms might include skin rash, itching, redness or swelling. Respiratory reactions may be characterized by rhinitis, sneezing, scratchy throat, oral mucosal edema, laryngeal mucosal edema, coughing, shortness of breath, wheezing, and chest pain. Asthma like reactions occur with acute exposures in sensitized patients. May be absorbed through the skin and cause systemic effects. May cause eye and skin irritation . Known Clinical Effects Drugs of this class may cause Cushing's syndrome, manifested by moon face, obesity, headache, acne, thirst, increased urination, impotence, menstrual irregularities, facial hair growth, and mental changes. Australian Hazard Classification (NOHSC)

Hazardous Ingredients

Non-Dangerous Goods Note This document has been prepared in accordance with standards for workplace safety, which requires the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warning included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.

2.1 Classification of the substance or mixture

Skin Sensitization: Category 1 Reproductive Toxicity: Category 1B Carcinogenicity: Category 1B EU Classification: EU Indication of danger: Carcinogenic: Category 2 EU Symbol: T EU Risk Phrases: R45 - May cause cancer. Label Elements